TPCera Ltd.

vlx.co.il

High-Tech Company

Graduated from: VLX Ventures

TECH VERTICALS

Biotechnology, Life Sciences, MedTech, Therapeutics

General Data

Sector	Biomed
Company Stage:	R&D
Established	2016
Number of Employees	3
Reg. Number:	abCDe

DESCRIPTION

TPCera is developing a breakthrough new immunomodulatory compound, invented by Prof. Yehuda Shoenfeld and Prof. Miri Blank. Autoimmune diseases are debilitating conditions that affect a large and growing portion of the population. There are over 80 different autoimmune diseases, affecting approximately 50 million Americans. These diseases are chronic and can be life-threatening; they are the second highest cause of chronic illness, and the top cause of morbidity in women in the United States.

TECHNOLOGY

Iimmunomodulatory compound for treating autoimmune diseases.

Products and Phases

Product	Phase
N/A	Phase I
Iimmunomodulatory compound for treating autoimmune diseases.

	TARGET MARKETS
	Pharmaceutical companies, People suffering from autoimmune diseases

	BUSINESS MODEL
	B2C

REMARKS

Date	Remark
01/01/2016	Tarsius Pharma has spun off from TPCera

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	1 Shim'on Rokah St.
City	Jerusalem
Country	Israel
Zip	9270401

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Prof. Yehuda Shoenfeld	Co-Inventor	Kidod (CMO)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	CEO, VLX Ventures
abC Defghij	Board Member	Managing Partner & Co-Founder, Israel Biotech Fund (IBF)

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

First Round

Nov. 29, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed

Jun. 01, 2016

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2016

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe